Correlation Between Trustcash Holdings and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trustcash Holdings and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trustcash Holdings and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trustcash Holdings and Moleculin Biotech, you can compare the effects of market volatilities on Trustcash Holdings and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trustcash Holdings with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trustcash Holdings and Moleculin Biotech.

Diversification Opportunities for Trustcash Holdings and Moleculin Biotech

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Trustcash and Moleculin is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Trustcash Holdings and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Trustcash Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trustcash Holdings are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Trustcash Holdings i.e., Trustcash Holdings and Moleculin Biotech go up and down completely randomly.

Pair Corralation between Trustcash Holdings and Moleculin Biotech

Given the investment horizon of 90 days Trustcash Holdings is expected to under-perform the Moleculin Biotech. In addition to that, Trustcash Holdings is 3.05 times more volatile than Moleculin Biotech. It trades about -0.21 of its total potential returns per unit of risk. Moleculin Biotech is currently generating about 0.03 per unit of volatility. If you would invest  262.00  in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Trustcash Holdings  vs.  Moleculin Biotech

 Performance 
       Timeline  
Trustcash Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trustcash Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Moleculin Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Trustcash Holdings and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trustcash Holdings and Moleculin Biotech

The main advantage of trading using opposite Trustcash Holdings and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trustcash Holdings position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.
The idea behind Trustcash Holdings and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal